Institutional investors purchased a net $2.6 million shares of PDLI during the quarter ended June 2015 and now own 92.67% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOTHAM ASSET MANAGEMENT LLC Bought 3.9 Million shares of PDL BioPharma Inc
FIRST TRUST ADVISORS LP Bought 3.4 Million shares of PDL BioPharma Inc
BMO CAPITAL MARKETS (CANADA) Bought 2.7 Million shares of PDL BioPharma Inc